These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

946 related articles for article (PubMed ID: 17705522)

  • 1. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
    Ueda K; Katagiri T; Shimada T; Irie S; Sato TA; Nakamura Y; Daigo Y
    J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative serum glycoproteomics using lectin selected sialic acid glycoproteins with mass spectrometric analysis: application to pancreatic cancer serum.
    Zhao J; Simeone DM; Heidt D; Anderson MA; Lubman DM
    J Proteome Res; 2006 Jul; 5(7):1792-802. PubMed ID: 16823988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A strategy for discovery of cancer glyco-biomarkers in serum using newly developed technologies for glycoproteomics.
    Narimatsu H; Sawaki H; Kuno A; Kaji H; Ito H; Ikehara Y
    FEBS J; 2010 Jan; 277(1):95-105. PubMed ID: 19919546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoproteomic analysis of WGA-bound glycoprotein biomarkers in sera from patients with lung adenocarcinoma.
    Hongsachart P; Huang-Liu R; Sinchaikul S; Pan FM; Phutrakul S; Chuang YM; Yu CJ; Chen ST
    Electrophoresis; 2009 Apr; 30(7):1206-20. PubMed ID: 19294700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS.
    Heo SH; Lee SJ; Ryoo HM; Park JY; Cho JY
    Proteomics; 2007 Dec; 7(23):4292-302. PubMed ID: 17963278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derivatized cellulose combined with MALDI-TOF MS: a new tool for serum protein profiling.
    Feuerstein I; Rainer M; Bernardo K; Stecher G; Huck CW; Kofler K; Pelzer A; Horninger W; Klocker H; Bartsch G; Bonn GK
    J Proteome Res; 2005; 4(6):2320-6. PubMed ID: 16335981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical methods for glycoprotein discovery.
    Bond MR; Kohler JJ
    Curr Opin Chem Biol; 2007 Feb; 11(1):52-8. PubMed ID: 17174139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted serum glycoproteomics for the discovery of lung cancer-associated glycosylation disorders using lectin-coupled ProteinChip arrays.
    Ueda K; Fukase Y; Katagiri T; Ishikawa N; Irie S; Sato TA; Ito H; Nakayama H; Miyagi Y; Tsuchiya E; Kohno N; Shiwa M; Nakamura Y; Daigo Y
    Proteomics; 2009 Apr; 9(8):2182-92. PubMed ID: 19322776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A glycomics approach to the discovery of potential cancer biomarkers.
    An HJ; Lebrilla CB
    Methods Mol Biol; 2010; 600():199-213. PubMed ID: 19882130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-linked glycosylation profiling of pancreatic cancer serum using capillary liquid phase separation coupled with mass spectrometric analysis.
    Zhao J; Qiu W; Simeone DM; Lubman DM
    J Proteome Res; 2007 Mar; 6(3):1126-38. PubMed ID: 17249709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH; Rustgi AK; Blair IA
    J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
    Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform.
    Pan S; Rush J; Peskind ER; Galasko D; Chung K; Quinn J; Jankovic J; Leverenz JB; Zabetian C; Pan C; Wang Y; Oh JH; Gao J; Zhang J; Montine T; Zhang J
    J Proteome Res; 2008 Feb; 7(2):720-30. PubMed ID: 18186601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of glycosylation patterns in serum using natural glycoprotein microarrays and multi-lectin fluorescence detection.
    Patwa TH; Zhao J; Anderson MA; Simeone DM; Lubman DM
    Anal Chem; 2006 Sep; 78(18):6411-21. PubMed ID: 16970316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global and targeted quantitative proteomics for biomarker discovery.
    Veenstra TD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients.
    El-Aneed A; Banoub J
    Anticancer Res; 2006; 26(5A):3293-300. PubMed ID: 17094443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel comprehensive approach for accessible biomarker identification and absolute quantification from precious human tissues.
    Turtoi A; Dumont B; Greffe Y; Blomme A; Mazzucchelli G; Delvenne P; Mutijima EN; Lifrange E; De Pauw E; Castronovo V
    J Proteome Res; 2011 Jul; 10(7):3160-82. PubMed ID: 21534635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific MALDI imaging and profiling for biomarker hunting and validation: fragment of the 11S proteasome activator complex, Reg alpha fragment, is a new potential ovary cancer biomarker.
    Lemaire R; Menguellet SA; Stauber J; Marchaudon V; Lucot JP; Collinet P; Farine MO; Vinatier D; Day R; Ducoroy P; Salzet M; Fournier I
    J Proteome Res; 2007 Nov; 6(11):4127-34. PubMed ID: 17939699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of accessible human cancer biomarkers using ex vivo chemical proteomic strategies.
    Kischel P; Waltregny D; Castronovo V
    Expert Rev Proteomics; 2007 Dec; 4(6):727-39. PubMed ID: 18067412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.